tirzepatide versus semaglutide once weekly in Patients with Type 2 Diabetes | NEJM Tirzepatide vs semaglutide dosage chart:

Patients should rotate injection sites (abdomen, thigh, or upper arm), allow the medication to reach room temperature before injection, and ensure proper technique

According to the FDA-approved prescribing information, patients start at 0.25 mg once weekly for the first four weeks (a dose-initiation phase not intended for blood sugar control), then increase to therapeutic doses

Elsevier BV, DOI 10.1016/j.diabet.2025.101636,

Is there any downtime after NAD injections

For those who choose to discontinue the medication, preparation and clear expectations matter

A basal background fluorescence of buffer or buffer containing 100 M NADPH was subtracted from the samples